Healthcare & Life Sciences
Vaximm
Switzerlandwww.vaximm.com
Vaximm is a Healthcare & Life Sciences startup based in Switzerland, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Vaximm
Based in Switzerland, Vaximm is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Vaximm develops oral, cytotoxic immunotherapies that activate systemic T-cell responses to target and treat cancer by leveraging the gut immune system.
Explore Vaximm's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.